Clinical trial
The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients…
NCT00314314 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00314314 |
|---|---|
| Title | The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder |
| Official title | A Randomized, Double-Blind Controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Hamilton Health Sciences Corporation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Intranasal Insulin, Diluent |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 13, 2006 |
| Last update posted | Jul 13, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: